{
    "organizations": [],
    "uuid": "0a6d265d9499e26011a307c9bae68919f6da7300",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cipher-pharmaceuticals-reports-qtr/brief-cipher-pharmaceuticals-reports-qtrly-total-net-revenue-increased-by-90-to-12-2-million-idUSASB0C7Z0",
    "ord_in_thread": 0,
    "title": "BRIEF-Cipher Pharmaceuticals Reports Qtrly ‍Total Net Revenue Increased By 90% To $12.2 Million​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Cipher Pharmaceuticals Inc:\n* CIPHER PHARMACEUTICALS REPORTS Q4 & FY2017 RESULTS * CIPHER PHARMACEUTICALS INC QTRLY ‍ TOTAL NET REVENUE INCREASED BY 90% TO $12.2 MILLION​\n* CIPHER PHARMACEUTICALS INC - QTRLY ‍INCOME FROM CONTINUING OPERATIONS OF $0.14 PER BASIC SHARE​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-02-28T20:06:00.000+02:00",
    "crawled": "2018-03-01T21:41:42.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "cipher",
        "pharmaceutical",
        "inc",
        "cipher",
        "pharmaceutical",
        "report",
        "q4",
        "fy2017",
        "result",
        "cipher",
        "pharmaceutical",
        "inc",
        "qtrly",
        "total",
        "net",
        "revenue",
        "increased",
        "cipher",
        "pharmaceutical",
        "inc",
        "qtrly",
        "continuing",
        "operation",
        "per",
        "basic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}